Last reviewed · How we verify
Antiemetic Combinations
Combination of antiemetic drugs to prevent nausea and vomiting.
Combination of antiemetic drugs to prevent nausea and vomiting. Used for Prevention of nausea and vomiting associated with chemotherapy.
At a glance
| Generic name | Antiemetic Combinations |
|---|---|
| Also known as | Steroids, Anti histamine |
| Sponsor | Tasnem Abo-elouon |
| Drug class | Antiemetic combination |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
This combination works by targeting multiple pathways involved in the regulation of nausea and vomiting, providing a more comprehensive approach to managing these symptoms.
Approved indications
- Prevention of nausea and vomiting associated with chemotherapy
Common side effects
- Headache
- Dizziness
- Fatigue
Key clinical trials
- Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations (PHASE2, PHASE3)
- Use of the Modified PUQE Score on Admitted Cases of Hyperemesis Gravidarum (HG) to Guide Response to Treatment
- Reducing Up-set Stomach and Vomiting After Surgery Using Essential Oils (NA)
- Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy (PHASE2)
- Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 Substudy (PHASE3)
- Prophylactic Dimenhydrinate for Intraoperative Nausea and Vomiting (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |